New registry aims to unlock secrets of rare childhood blood-clotting disorder
NCT ID NCT00616317
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is creating a registry to collect information from children diagnosed with antiphospholipid syndrome (APS), a condition that causes abnormal blood clots. Researchers aim to better understand what causes APS and how it is treated, with a focus on long-term survival. The study will enroll up to 50 participants who were 18 or younger at disease onset and meet specific lab criteria.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTIPHOSPHOLIPID SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UC Davis Medical Center
RECRUITINGSacramento, California, 95817, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood platelet trends may reveal hidden risk in autoimmune disease
- Immune clues in the blood may foretell heart trouble
- Can a simple blood test tell two forms of a clotting disorder apart?
- New fingerstick test for blood thinner monitoring put to the test
- New MRI study seeks hidden stroke causes in rare blood disorder
- New hope for stroke survivors with rare clotting disorder: rivaroxaban vs warfarin